|
시장보고서
상품코드
2054933
리소자임 시장 : 치료 용도별, 제품 유형별, 제형별, 투여 경로별, 제제 유형별, 최종 사용자별, 유통 채널별, 지역별Lysozyme Market, By Therapeutic Application, By Product Type, By Form, By Route of Administration (Oral, Parenteral, Topical, and Others ), By Formulation Type, By End User, By Distribution Channel, By Geography |
||||||
리소자임 시장은 2026년에 6억 5,130만 달러에 달하고 2033년까지 10억 8,060만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR은 7.5%를 나타낼 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 6억 5,130만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 7.50% | 시장 규모 예측(2033년) : | 10억 8,060만 달러 |
세계 리소자임 시장은 이 천연 유래 항균 효소가 지닌 다기능성에 힘입어, 생명공학 및 제약 업계에서 중요한 부문을 차지하고 있습니다. 주로 달걀 흰자, 인체 분비물 및 박테리아 유래 리소자임은 식품 보존에서 의약품 제제에 이르기까지 다양한 용도에서 필수적인 성분으로 기능하고 있습니다. 세균의 세포벽을 분해하는 이 효소의 능력은 미생물 감염과의 싸움이나 다양한 산업 분야에서 제품의 유통기한을 연장하는 데 있어 매우 귀중한 자산이 되고 있습니다.
이 시장에는 난백 리소자임, 히토리소자임, 재조합 리소자임 등 다양한 제품 유형이 포함되어 있으며, 각각이 특정 산업의 요구를 충족시키고 있습니다. 주요 용도 분야로는 식품 및 음료, 의약품, 퍼스널케어 제품, 동물사료 등이 있으며, 리소자임의 천연 항균 특성은 합성 방부제를 대체할 수 있는 지속 가능한 대안을 제공합니다. 천연 성분에 대한 소비자의 선호도가 높아지는 데다, 식품 안전성과 의약품 품질을 규제하는 엄격한 기준 덕분에, 효과적이면서도 천연 유래의 항균 솔루션을 찾는 제조업체들에게 리소자임은 최적의 선택지로 자리매김하고 있습니다. 시장의 성장세는 생명공학 연구의 진전, 혁신적인 생산 방식, 그리고 신흥 치료 분야에서의 적용 범위 확대로 인해 더욱 가속화되고 있으며, 리소자임 시장은 막대한 상업적 잠재력을 지닌 역동적이고 지속적으로 진화하는 분야로 자리매김하고 있습니다.
시장 역학
세계 리소자임 시장은 몇 가지 주요 시장 성장 촉진요인에 의해 견인되고 있으며, 이러한 요인들이 복합적으로 작용하여 견실한 성장 궤도에 기여하고 있습니다. 주요 시장 성장 요인은 소비자들이 클린 라벨 제품을 점점 더 중요하게 여기고, 제조업체들이 합성 방부제의 대체재를 모색함에 따라 식품, 의약품 및 퍼스널케어 산업 전반에서 천연 항균제에 대한 수요가 증가하고 있다는 점입니다. 특히 개발도상국에서 식품 및 음료 부문의 성장은 식품 보존 분야에서 리소자임의 활용을 위한 큰 기회를 창출하고 있습니다. 한편, 천연 치료 화합물에 대한 관심이 높아지고 있는 제약 업계에서는 의약품 제제 및 상처 치유 용도로 사용되는 의약품 등급 리소자임에 대한 수요가 증가하고 있습니다. 또한, 항생제 내성에 대한 인식이 높아짐에 따라 리소자임은 매력적인 대체 항균제로서의 입지를 확고히 하고 있으며, 다양한 병원성 미생물에 대한 그 효능을 입증하는 광범위한 조사 결과로 뒷받침되고 있습니다.
그러나 시장에는 중대한 제약도 존재합니다. 리소자임의 추출 및 정제 공정에 따른 높은 생산 비용이, 비용 효율성을 중시하는 용도나 신흥 시장에서의 도입을 제한하고 있습니다. 특히 달걀 흰자 공급원과 관련된 원자재 조달의 어려움은 공급망상의 과제가 되고 있으며, 지역별 복잡한 규제는 시장 진입 및 제품 표준화의 걸림돌이 되고 있습니다. 특정 조건 하에서 리소자임의 저장 안정성이 낮다는 점과 과민 반응을 보이는 개인에게서 발생할 수 있는 잠재적인 알레르기 반응 또한 시장 확대를 더욱 제한하고 있습니다. 그럼에도 불구하고, 재조합 리소자임 생산을 가능하게 하는 생명공학의 발전으로 인해, 공급 제한이나 알레르기 관련 우려를 해결하는 동시에 생산 비용 절감도 기대할 수 있는 큰 기회가 열리고 있습니다. 확대되는 뉴트라슈티컬 시장, 수의학 분야에서의 용도 확대, 개발도상국에서의 도입 증가, 그리고 다양한 질환 치료에 대한 잠재적 치료 용도는 리소자임의 다양한 기능적 특성을 활용하려는 시장 진출기업들에게 수익성 높은 성장 기회를 제시하고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 파라미터(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)를 바탕으로 세계 리소자임 시장의 주요 기업 프로파일을 작성하였습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 리소자임 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 세계의 리소자임 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적 및 전제 조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 리소자임 시장 : 치료 용도별(2021-2033년)
제5장 세계의 리소자임 시장 : 제품 유형별(2021-2033년)
제6장 세계의 리소자임 시장 : 제형별(2021-2033년)
제7장 세계의 리소자임 시장 : 투여 경로별(2021-2033년)
제8장 세계의 리소자임 시장 : 제제 유형별(2021-2033년)
제9장 세계의 리소자임 시장 : 최종 사용자별(2021-2033년)
제10장 세계의 리소자임 시장 : 유통 채널별(2021-2033년)
제11장 세계의 리소자임 시장 : 지역별(2021-2033년)
제12장 경쟁 구도
제13장 애널리스트의 제안
제14장 참고 문헌 및 조사 방법
KTH 26.06.19Lysozyme Market is estimated to be valued at USD 651.3 Mn in 2026 and is expected to reach USD 1080.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 651.3 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.50% | 2033 Value Projection: | USD 1080.6 Mn |
The global lysozyme market represents a significant segment within the biotechnology and pharmaceutical industries, driven by the multifunctional properties of this naturally occurring antimicrobial enzyme. Lysozyme, primarily derived from egg whites, human secretions, and bacterial sources, serves as a crucial component in various applications ranging from food preservation to pharmaceutical formulations. This enzyme's ability to break down bacterial cell walls makes it an invaluable asset in combating microbial infections and extending product shelf life across multiple industries.
The market encompasses diverse product types including egg white lysozyme, human lysozyme, and recombinant lysozyme, each serving specific industrial requirements. Key application sectors include food and beverages, pharmaceuticals, personal care products, and animal feed, where lysozyme's natural antimicrobial properties provide sustainable alternatives to synthetic preservatives. The increasing consumer preference for natural ingredients, coupled with stringent regulatory frameworks governing food safety and pharmaceutical quality, has positioned lysozyme as a preferred choice for manufacturers seeking effective yet natural antimicrobial solutions. The market's growth trajectory is further supported by advancing biotechnology research, innovative production methods, and expanding applications in emerging therapeutic areas, making it a dynamic and evolving sector with substantial commercial potential.
Market Dynamics
The global lysozyme market is propelled by several key drivers that collectively contribute to its robust growth trajectory, with the primary driver being the escalating demand for natural antimicrobial agents across food, pharmaceutical, and personal care industries as consumers increasingly prioritize clean-label products and manufacturers seek alternatives to synthetic preservatives. The expanding food and beverage sector, particularly in developing economies, creates substantial opportunities for lysozyme application in food preservation, while the growing pharmaceutical industry's focus on natural therapeutic compounds drives demand for pharmaceutical-grade lysozyme in drug formulations and wound healing applications. Additionally, the rising awareness of antibiotic resistance has positioned lysozyme as an attractive alternative antimicrobial agent, supported by extensive research demonstrating its efficacy against various pathogenic microorganisms.
However, the market faces significant restraints including the high production costs associated with lysozyme extraction and purification processes, which limit its adoption in cost-sensitive applications and emerging markets. Raw material availability constraints, particularly concerning egg white sources, pose supply chain challenges, while regulatory complexities across different regions create barriers to market entry and product standardization. The limited shelf stability of lysozyme under certain conditions and potential allergenic reactions in sensitive individuals further constrain market expansion. Nevertheless, substantial opportunities emerge from advancing biotechnology enabling recombinant lysozyme production, which addresses supply limitations and allergenicity concerns while potentially reducing production costs. The expanding nutraceutical market, growing applications in veterinary medicine, increasing adoption in developing regions, and potential therapeutic applications in treating various diseases present lucrative growth avenues for market participants seeking to capitalize on lysozyme's diverse functional properties.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global lysozyme market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include dsm-firmenich, Bioseutica BV, WAKO Chemicals, Danish Bioscience, Qingdao Vland Biotech, Amano Enzyme Inc, Lysozyme Corporation, Nanning Doing-Higher Bio-Tech, Jiangsu Yiming Biological, Jiangxi Shineway Pharmaceutical, Handary SA, Bouwhuis Enthoven, AgraFood Ingredients BV, Neova Technologies, and Chr Hansen A/S
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global lysozyme market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lysozyme market
Market Segmentation
- Therapeutic Application Insights (Revenue, USD Mn, 2021 - 2033)
- Anti-infective Therapies
- Anti-inflammatory Therapies
- Gastrointestinal Infection Management
- Respiratory Infection Management
- Wound-Healing and Tissue Repair
- Immunomodulatory Applications
- Other Therapeutic Uses
- Product Type Insights (Revenue, USD Mn, 2021 - 2033)
- Recombinant Lysozyme
- Natural Lysozyme
- Form Insights (Revenue, USD Mn, 2021 - 2033)
- Lysozyme Solution
- Lysozyme Powder
- Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
- Oral
- Parenteral
- Topical
- Others (Nasal)
- Formulation Type Insights (Revenue, USD Mn, 2021 - 2033)
- Monotherapies
- Combination Therapies
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Pharmaceutical Manufacturers
- Biotechnology Companies
- Hospitals and Clinics
- Research Institutes
- Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
- Online
- Offline
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- dsm-firmenich
- Bioseutica BV
- WAKO Chemicals
- Danish Bioscience
- Qingdao Vland Biotech
- Amano Enzyme Inc
- Lysozyme Corporation
- Nanning Doing-Higher Bio-Tech
- Jiangsu Yiming Biological
- Jiangxi Shineway Pharmaceutical
- Handary SA
- Bouwhuis Enthoven
- AgraFood Ingredients BV
- Neova Technologies
- Chr Hansen A/S
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Lysozyme Market, By Therapeutic Application
- Global Lysozyme Market, By Product Type
- Global Lysozyme Market, By Form
- Global Lysozyme Market, By Route of Administration
- Global Lysozyme Market, By Formulation Type
- Global Lysozyme Market, By End User
- Global Lysozyme Market, By Distribution Channel
- Global Lysozyme Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Lysozyme Market, By Therapeutic Application, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Anti-infective Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Anti-inflammatory Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Gastrointestinal Infection Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Respiratory Infection Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Wound-Healing and Tissue Repair
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Immunomodulatory Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Other Therapeutic Uses
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
5. Global Lysozyme Market, By Product Type, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Recombinant Lysozyme
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Natural Lysozyme
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
6. Global Lysozyme Market, By Form, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Lysozyme Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Lysozyme Powder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
7. Global Lysozyme Market, By Route of Administration, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others (Nasal)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
8. Global Lysozyme Market, By Formulation Type, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Monotherapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Combination Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
9. Global Lysozyme Market, By End User, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical Manufacturers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
10. Global Lysozyme Market, By Distribution Channel, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Online
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Offline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
11. Global Lysozyme Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- dsm-firmenich
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bioseutica BV
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- WAKO Chemicals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danish Bioscience
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Qingdao Vland Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amano Enzyme Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lysozyme Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nanning Doing-Higher Bio-Tech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jiangsu Yiming Biological
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jiangxi Shineway Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Handary SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bouwhuis Enthoven
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AgraFood Ingredients BV
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Neova Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Chr Hansen A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us
